Abeona Therapeutics Inc.
ABEO
$5.29
$0.428.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -22.16% | -39.21% | |||
| Gross Profit | 16.64% | 43.24% | |||
| SG&A Expenses | 12.62% | 75.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.56% | 17.56% | |||
| Operating Income | -5.38% | -15.54% | |||
| Income Before Tax | -116.37% | 1,133.71% | |||
| Income Tax Expenses | -197.97% | -- | |||
| Earnings from Continuing Operations | -104.74% | 1,004.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -104.74% | 1,004.76% | |||
| EBIT | -5.38% | -15.54% | |||
| EBITDA | -5.22% | -15.92% | |||
| EPS Basic | -104.59% | 957.62% | |||
| Normalized Basic EPS | 29.63% | -120.79% | |||
| EPS Diluted | -105.86% | 806.00% | |||
| Normalized Diluted EPS | 10.73% | -74.04% | |||
| Average Basic Shares Outstanding | 3.27% | 5.52% | |||
| Average Diluted Shares Outstanding | -18.60% | 33.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||